| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Teirlinck Didier P | Director | 909 ROSE AVE, 8TH FLOOR, NORTH BETHESDA | /s/ Curtis E. Jewell, Attorney-in-Fact | 2025-05-12 | 0001437676 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESAB | Stock Option (right to buy) | Award | $0 | +1.86K | $0.00 | 1.86K | May 8, 2025 | Common stock, par value $0.001 | 1.86K | $125.93 | Direct | F1 | |
| transaction | ESAB | Deferred Stock Units | Award | $0 | +637 | $0.00 | 637 | May 8, 2025 | Common stock, par value $0.001 | 637 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | These stock options vested and became exercisable on the grant date. |
| F2 | Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. |
| F3 | These deferred stock units vest in a single installment on June 1, 2026. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company. |